Skip to content

Keller Eric L.

Reporting owner on Forms 3, 4 and 5, CIK 2156365.

Keller Eric L. reported on 1 issuer in 4 filings, the latest a Form 4 filed 2026-10-22.

Issuers

IssuerRoles in the latest filingFilingsLast filed
Retension Pharmaceuticals, Inc. CIK 2002988director, officer (CHIEF EXECUTIVE OFFICER)32026-10-22

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
Retension Pharmaceuticals, … Stock Option (right to buy), derivative2026-10-22A granted+40,884$040,884Form 4
Retension Pharmaceuticals, … Common Stock2026-10-13P bought+20,800$12423,377Form 4
Retension Pharmaceuticals, … Common Stock2026-10-13C converted+9,662433,039Form 4
Retension Pharmaceuticals, … Common Stock2026-10-13C converted+31,368464,407Form 4
Retension Pharmaceuticals, … Stock Option (right to buy), derivative2026-10-13A granted+255,174$0255,174Form 4
Retension Pharmaceuticals, … Series A Convertible Preferred Stock, derivative2026-10-13C converted-9,6620Form 4
Retension Pharmaceuticals, … Series B Convertible Preferred Stock, derivative2026-10-13C converted-31,3680Form 4
Retension Pharmaceuticals, … Common Stock, holding 402,577Form 3
Retension Pharmaceuticals, … Stock Option (right to buy), derivative, holding Form 3
Retension Pharmaceuticals, … Stock Option (right to buy), derivative, holding Form 3
Retension Pharmaceuticals, … Stock Option (right to buy), derivative, holding Form 3
Retension Pharmaceuticals, … Series A Convertible Preferred Stock, derivative, holding Form 3
Retension Pharmaceuticals, … Series B Convertible Preferred Stock, derivative, holding Form 3

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001213900-26-111795 Retension Pharmaceuticals, Inc.2026-10-22
13D 0001213900-26-109425 RTSN2026-10-14
Form 4 0001213900-26-109160 Retension Pharmaceuticals, Inc.2026-10-13
Form 3 0001213900-26-108135 Retension Pharmaceuticals, Inc.2026-10-08